Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Fandos · SciRah

Researcher profile · Semantic Scholar

N. Fandos

Share profile

N. Fandos — researcher profile on SciRah

h-index: 11
Works: 33
Citations: 888

Most-cited papers

Characterization of pre-analytical sample handling effects on a panel of Alzheimer’s-related blood-based biomarkers. Results from the Standardization of Alzheimer’s Blood Biomarkers (SABB) working group
I. Verberk, Els O. Misdorp, Jannet Koelewijn, Andrew J. Ball +18 more
2021Alzheimer's & Dementia215 citations Open access
Semantic Scholar
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
N. Fandos, V. Pérez-Grijalba, P. Pesini, S. Olmos +6 more
2017Alzheimer's & Dementia180 citations Open access
Semantic Scholar
Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
J. Doecke, V. Pérez-Grijalba, N. Fandos, C. Fowler +4 more
2020Neurology169 citations Open access
Semantic Scholar
Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
M. Izco, P. Martínez, Andrea Corrales, N. Fandos +9 more
2014Neuroscience45 citations
Semantic Scholar
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
M. Pascual-Lucas, J. Allué, L. Sarasa, N. Fandos +71 more
2023Alzheimer's Research & Therapy38 citations Open access
Semantic Scholar
The global Alzheimer's Association round robin study on plasma amyloid β methods
Josef Pannee, L. Shaw, M. Korecka, T. Waligórska +31 more
2021Alzheimer's & Dementia36 citations Open access
Semantic Scholar
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
S. Burnham, N. Fandos, C. Fowler, V. Pérez-Grijalba +10 more
2020Brain Communications32 citations Open access
Semantic Scholar
Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma
V. Pérez-Grijalba, N. Fandos, J. Canudas, D. Insua +5 more
2016Journal of Alzheimer's Disease26 citations Open access
Semantic Scholar
Optimized Protocol for Amyloid-β Extraction from the Brain
M. Izco, P. Pesini, V. Pérez-Grijalba, N. Fandos +1 more
2013Journal of Alzheimer's Disease12 citations Open access
Semantic Scholar
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease
J. Allué, L. Sarasa, M. Izco, V. Pérez-Grijalba +5 more
2016Journal of Alzheimer's Disease11 citations Open access
Semantic Scholar
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double‐blind, placebo‐controlled phase 2 study
M. Pascual-Lucas, Ana-María Lacosta, M. Montanes, J. Canudas +12 more
2025Alzheimer's & Dementia8 citations Open access
Semantic Scholar
Safety, tolerability and immunogenicity of an active anti‐Aβ40 vaccine (ABvac40) in patients with amnestic mild cognitive impairment (A‐MCI) or very mild alzheimer’s disease (VM‐AD): A randomized, double‐blind, placebo‐controlled, phase II trial
Elisabet P. Molina, P. Pesini, Manuel Sarasa‐SanJose, Ivan Marcos +5 more
2020Alzheimer's & Dementia5 citations Open access
Semantic Scholar
AB1601 topline results – Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a‐MCI) or very mild Alzheimer’s Disease (Vm‐AD).
Elisabet P. Molina, Sergio Castillo, Ana-María Lacosta, J. Allué +6 more
2022Alzheimer's & Dementia3 citations
Semantic Scholar
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old
G. Fernández-Eulate, Ainhoa Alberro, M. Muñoz-Culla, M. Zulaica +18 more
2018Frontiers in Aging Neuroscience3 citations Open access
Semantic Scholar
Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer’s disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort
N. Fandos, M. Pascual-Lucas, L. Sarasa, J. Terencio +96 more
2026The journal of prevention of Alzheimer's disease2 citations Open access
Semantic Scholar
Clinical validation of a plasma-based antibody-free LC–MS method for identifying CSF amyloid positivity in mild cognitive impairment
J. Allué, L. Sarasa, N. Fandos, Ricardo Gonzalo +8 more
2025Frontiers in Aging Neuroscience2 citations Open access
Semantic Scholar
ABTEST‐IA: A new reliable tool for the quantification of Aβ40 and Aβ42 in CSF
N. Fandos, J. Romero, M. Pascual-Lucas, D. Alcolea +1 more
2023Alzheimer's & Dementia1 citations Open access
Semantic Scholar
Stability of the novel blood‐based biomarkers under pre‐analytical sample handling conditions: Results of the SABB‐GBSC working group
I. Verberk, Els O. Misdorp, Jannet Koelewijn, Andrew J. Ball +14 more
2021Alzheimer's & Dementia1 citations
Semantic Scholar
The Aβ42/Aβ40 ratio in plasma is associated with amyloid‐PET status and rate of progression in individuals with subjective cognitive decline: The Fundació ACE Healthy Brain Initiative
I. de Rojas, N. Fandos, J. Romero, P. Pesini +7 more
20201 citations Open access
Semantic Scholar
Long‐term safety and immunogenicity of ABvac40 active immunotherapy in mild cognitive impairment and very mild Alzheimer's disease: Results from AB1601 phase 2 extension study
M. Pascual-Lucas, Ana-María Lacosta, M. Montanes, J. Canudas +12 more
2026Alzheimer's & Dementia0 citations Open access
Semantic Scholar
Plasma Aβ42/Aβ40 predicts longitudinal amyloid pathology and clinical progression in amyloid-PET negative individuals with subjective cognitive decline
N. Fandos, M. Pascual-Lucas, L. Sarasa, Jorge Loscos +82 more
2026Alzheimer's Research & Therapy0 citations Open access
Semantic Scholar
Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217–based assessment of CSF amyloid positivity in secondary-care patients with MCI
M. Pascual-Lucas, L. Sarasa, N. Fandos, Jorge Loscos +9 more
2026Frontiers in Aging Neuroscience0 citations Open access
Semantic Scholar
Integrating Plasma pTau‐217 and Aβ42/Aβ40 Ratio for Accurate Non‐Invasive Prediction of Brain Amyloid Accumulation
J. Allué, L. Sarasa, M. Pascual-Lucas, N. Fandos +7 more
2025Alzheimer's & Dementia0 citations Open access
Semantic Scholar
P4‐273: ASSOCIATION BETWEEN PLASMA Aβ LEVELS AND CEREBRAL AMYLOID AND TAU DEPOSITION
S. Risacher, N. Fandos, J. Romero, I. Sherriff +2 more
20180 citations
Semantic Scholar
P4‐189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF Aβ40 LEVELS IN PLASMA
Ana-María Lacosta, N. Fandos, V. Pérez-Grijalba, P. Pesini +1 more
20180 citations
Semantic Scholar
P4‐238: Total plasma Aβ42/40 ratio is an early biomarker of Alzheimer's disease progression
P. Pesini, V. Pérez-Grijalba, N. Fandos, S. Olmos +7 more
20150 citations Open access
Semantic Scholar
THE INFLUENCE OF THE CENTRIFUGATION SETTINGS ON AB QUANTIFICATION IN PLASMA
N. Fandos, P. Pesini, I. Marcos-Campos, Virginia Pérez +1 more
2014Alzheimer's & Dementia0 citations
Semantic Scholar
P3‐083: THE EFFECT OF PREANALYTICAL FACTORS IN THE QUANTIFICATION OF AB IN PLASMA
N. Fandos, P. Pesini, Virginia Pérez, I. Marcos-Campos +1 more
20140 citations
Semantic Scholar
P1–244: Validation of beta‐amyloid test as a reliable tool for quantifying beta‐amyloid 1–40 and beta‐amyloid 1–42 in blood
Virginia Pérez, N. Fandos, P. Pesini, M. Sarasa
20130 citations
Semantic Scholar
The global Alzheimer's Association round robin study on plasma The global Alzheimer's Association round robin study on plasma amyloid β methods amyloid methods
Josef Pannee, Leslie M. Shaw, M. Korecka, T. Waligórska +31 more
0 citations
Semantic Scholar
PLASMA A b AND CEREBRAL AND DEPOSITION THE GUT MICROBIOTA-DERIVED METABOLITE TRIMETHYLAMINE N-OXIDE (TMAO) IS ELEVATED IN ALZHEIMER’S
N. Fandos, J. Romero, I. Sherriff, A. Saykin +12 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Sarasa×19
Invite
M. Sarasa — researcher profile on SciRah
P. Pesini×16
Invite
P. Pesini — researcher profile on SciRah
J. Allué×14
Invite
J. Allué — researcher profile on SciRah
M. Pascual-Lucas×13
Invite
M. Pascual-Lucas — researcher profile on SciRah

×13

Invite

L. Sarasa — researcher profile on SciRah

V. Pérez-Grijalba×12

Invite

V. Pérez-Grijalba — researcher profile on SciRah

Invite

J. Romero — researcher profile on SciRah

Invite

J. Terencio — researcher profile on SciRah

Ana-María Lacosta×7

Invite

Ana-María Lacosta — researcher profile on SciRah

Jorge Loscos×6

Invite

Jorge Loscos — researcher profile on SciRah

Invite

K. Blennow — researcher profile on SciRah

H. Zetterberg×5

Invite

H. Zetterberg — researcher profile on SciRah